Maltodextrin Market Size & Share 2026-2035

Maltodextrin Market Size

The global maltodextrin market was valued at USD 4.1 billion in 2025 and It is projected to reach USD 6.1 billion by 2035 at a 4.3% CAGR during 2026–2035.

Maltodextrin is a partially hydrolyzed starch polymer with a dextrose equivalent (DE) below 20 ^{[1]U.S. Food and Drug Administration, 21 CFR § 184.1444: Maltodextrin, law.cornell.edu}. Its commercial relevance rests on a useful trade-off: as DE rises, solubility and sweetness increase while molecular chain length, viscosity, and film-forming behavior decline . This allows a processor to sell function rather than simply carbohydrate volume. Low-DE grades support body, moisture management, and fat replacement; mid-DE material is widely suited to spray-dried carrier systems; and high-DE grades meet applications requiring rapid dissolution and lower viscosity , .

The supply base is shaped by both crop geography and processing configuration. Corn wet milling provides the largest integrated platform, while wheat and potato starch support European specialty supply, and cassava processing underpins Southeast Asian export flows. Drying is a critical economic step because it converts syrup into a transportable powder while concentrating energy use. Consequently, a producer's margin is determined not only by starch availability but also by co-product economics, energy exposure, specification control, and the ability to qualify a grade for a particular customer application.

Commodity inputs remained an important source of variability. U.S. nearby corn futures fell about 31% during 2023 as supply expanded ^{[2]Food Business News, Reviewing the 2023 Commodity Market Performance, 2024, foodbusinessnews.net}, whereas European starch processors continued to face high energy costs and lower paper-sector demand in early 2024 . Trade data also show why cassava-origin supply matters: Thailand exported USD 932 million of HS 350510 dextrins and modified starches in 2023, while the United States exported USD 500 million . These trade flows do not measure maltodextrin alone, but they indicate the scale and direction of the starch-derivative networks from which the market draws supply.

The projected 4.3% CAGR is consistent with this two-speed market. Food-grade volume remains the revenue foundation, while pharmaceutical, encapsulation, and certified non-GMO grades create the higher-growth pockets. Thailand's large HS 350510 export position increases the strategic significance of cassava sourcing, especially where formulators value non-corn origin. At the same time, qualification requirements in pharmaceutical supply make scale alone insufficient. The firms most able to convert growth into margin should be those that pair reliable starch access with controlled DE ranges, traceability, and formulation capability.

Key Drivers

Food-system functionality and processed-food demand. Maltodextrin occupies a broad set of food-manufacturing roles: it can carry flavors, manage solids, assist spray drying, modify texture, and help control moisture. Those functions make it difficult to replace with a single alternative across bakery, dairy, powdered beverages, confectionery, and dry mixes. The practical procurement consequence is that grade selection follows the process requirement. Low-DE material favors viscosity and film formation, while a more soluble grade may be selected for a powder beverage or an instant system ^{[3]MDPI, Molecules, Technological Application of Maltodextrins According to the Degree of Polymerization, 2015, mdpi.com}, . Food grade and food-and-beverage applications are each valued at USD 2.76 billion in 2025 and are projected to reach USD 4.015 billion by 2035, advancing at 3.8% CAGR.

Pharmaceutical and nutrition formulation. Pharmaceutical demand is expanding from a smaller base because the ingredient can serve as a binder, filler, protective matrix, or carrier rather than merely a caloric input. Published work identifies maltodextrin in orally disintegrating tablet systems ^{[4]PubMed Central, Maltodextrin: A Novel Excipient Used in Sugar-Based Orally Disintegrating Tablets and Phase Transition Process, pmc.ncbi.nlm.nih.gov}, while protein-lyophilization research demonstrates its potential as a protective matrix . The U.S. Pharmacopeia's proposed HPLC-based approach to reducing-sugars/DE testing illustrates why pharmaceutical-grade supply is a quality-system business as much as a starch-processing business . The pharmaceutical application segment is projected to increase from USD 0.64 billion in 2025 to USD 1.16 billion in 2035 at 6.1% CAGR. Suppliers that can maintain DE consistency, analytical control, and documentation gain access to accounts where changing an approved excipient has a higher operational cost than changing a commodity ingredient.

Cosmetics, healthcare expansion, and specialty distribution. In the EU cosmetic ingredient inventory, maltodextrin is assigned functions including absorbent, binding, emulsion-stabilizing, film-forming, hair-conditioning, and skin-conditioning . This extends demand beyond food, particularly where formulations require a carrier or texture modifier. Specialty retail and e-commerce broaden access to powdered supplements and personal-care formats, while expanding healthcare manufacturing in Asia Pacific supports demand for qualified excipient supply. These forces favor differentiated grades over undifferentiated bulk volume.

Encapsulation and clean-label differentiation. Maltodextrin's film-forming and matrix properties make it useful in spray-dried encapsulation of sensitive ingredients. Reviews of wall materials identify DE as an important determinant of matrix performance . At the same time, Ingredion's technical documentation for a tapioca-based non-GMO maltodextrin shows how origin and chain-of-custody become part of the commercial specification, not simply a raw-material choice . Cassava-based maltodextrin is projected to rise from USD 0.24 billion in 2025 to USD 0.427 billion in 2035 at 5.9% CAGR. Its relative growth reflects the ability to align source identity, clean-label positioning, and functional use in premium powdered products.

Key Restraints

Feedstock and energy exposure. Maltodextrin producers cannot fully separate their economics from agricultural cycles. Corn, wheat, potato, and cassava availability affect starch cost, while drying turns energy cost into a direct margin variable. The 2023 decline in U.S. corn futures provided input-cost relief in North America , but it also creates pressure for customers to renegotiate ingredient prices. In Europe, Reuters reported production reductions by starch makers as demand fell and costs remained challenging . Smaller processors without multi-origin procurement or durable customer contracts are consequently more exposed to abrupt changes in both input cost and selling-price expectations.

Qualification, labeling, and analytical requirements. U.S. food use is governed by the maltodextrin standard in 21 CFR 184.1444 , while pharmaceutical customers require a more demanding quality and documentation environment. The proposed USP analytical update highlights a practical barrier: a supplier must demonstrate grade consistency with methods acceptable to the customer's regulatory framework. This raises the cost of entering pharmaceutical-grade supply but can also reinforce incumbent positions once a material has been qualified. For corn-derived products, non-GMO, allergen, and origin-related requests add a separate traceability burden.

Process sustainability. The drying stage is a focal point for decarbonization because it is energy intensive. Avebe identifies spray drying among the areas targeted in its program to reduce CO2 emissions by 30% by 2030 . Investments in steam systems, concentration technology, and wastewater management may improve long-run competitiveness, but their payback depends on energy economics and customer willingness to recognize lower-carbon processing in purchasing decisions. The immediate effect is a capital and operating-cost hurdle for producers competing in price-sensitive grades.

This makes investment sequencing consequential. A producer facing volatile corn or wheat costs can diversify feedstock, but a move into pharmaceutical or encapsulation grades also requires analytical capability and customer qualification. The more stringent the customer's specification, the less effective a purely price-led strategy becomes. Sustainability upgrades at drying operations compound this divide: they may lower future operating risk, but firms with constrained capital may find it difficult to make the transition while defending current margins.

Maltodextrin Market Segment Analysis

By Source

Corn-based maltodextrin is the largest source segment, projected to advance from USD 2.88 billion in 2025 to USD 4.271 billion in 2035 at 4.0% CAGR. Its scale reflects the installed corn wet-milling base and co-product economics. Wheat-based material is projected to grow from USD 0.48 billion to USD 0.794 billion at 5.2% CAGR, supported by European starch-processing systems and source-specific formulation requirements. Potato-based maltodextrin is projected to increase from USD 0.28 billion to USD 0.427 billion at 4.3% CAGR. Avebe's six production sites across the Netherlands, Germany, and Sweden illustrate the regional industrial base behind potato-starch specialization ^{[5]Royal Avebe, Integrated Annual Report 2023/2024, publications.avebe.com}.

Cassava-based maltodextrin is projected to grow fastest by source, from USD 0.24 billion in 2025 to USD 0.427 billion in 2035 at 5.9% CAGR. Thailand's large starch-derivative export flow ^{[6]World Bank WITS, Dextrins and Other Modified Starches (HS 350510), Exports by Country, 2023, wits.worldbank.org} gives the segment an established export platform, but concentration also makes logistics and crop conditions in Southeast Asia commercially relevant to overseas buyers. Other sources, including rice, are projected to rise from USD 0.12 billion to USD 0.186 billion at 4.5% CAGR. FDA documentation confirms GRAS affirmation for rice-starch-derived maltodextrin , supporting its use as a differentiated source where customer specifications call for it.

By Grade

Food grade remains the largest grade segment, projected to increase from USD 2.76 billion in 2025 to USD 4.015 billion in 2035 at 3.8% CAGR. Its large base reflects the ingredient's recurring role in food processing, but its growth rate also shows the maturity of conventional volume markets. Pharmaceutical grade is projected to expand from USD 0.84 billion to USD 1.465 billion at 5.7% CAGR. Roquette's GLUCIDEX IT 19, specified at DE 19 for oral dosage and nutraceutical applications, illustrates the tighter functional and regulatory positioning associated with this segment . Industrial grade is projected to rise from USD 0.32 billion to USD 0.549 billion at 5.5% CAGR, while other grades decline from USD 0.08 billion to USD 0.076 billion at 0.7% CAGR, suggesting that niche uses without a distinct qualification or application advantage face substitution pressure.

By Application

Food and beverages are projected to grow from USD 2.76 billion in 2025 to USD 4.015 billion in 2035 at 3.8% CAGR. The segment is a volume anchor, but the procurement logic is application-specific: a bakery or frozen-dessert producer values moisture and body, while a powder producer prioritizes dispersibility and carrier performance. Pharmaceuticals are projected to grow from USD 0.64 billion to USD 1.16 billion at 6.1% CAGR, making them the fastest-growing application. Cosmetics and personal care are projected to rise from USD 0.40 billion to USD 0.611 billion at 4.3% CAGR, enabled by the ingredient's recognized formulation functions . Industrial applications are projected to increase from USD 0.16 billion to USD 0.258 billion at 5.0% CAGR; other applications are projected to move from USD 0.04 billion to USD 0.061 billion at 4.3% CAGR.

By DE Range

Low DE (3–9) maltodextrin is projected to grow from USD 1.61 billion in 2025 to USD 2.32 billion in 2035 at 3.8% CAGR. Its chain length and lower sweetness favor food systems requiring body, moisture control, or film formation. Mid DE (10–16) is projected to rise from USD 1.56 billion to USD 2.381 billion at 4.3% CAGR, reflecting its balance of solubility and matrix behavior in encapsulation and powder systems . High DE (17–20) is projected to increase from USD 0.84 billion to USD 1.404 billion at 5.3% CAGR. Its dissolution profile supports sports-nutrition and oral-dose applications; Roquette's DE-19 grade demonstrates how a high-DE material can be sold into a qualified specialty use rather than only into a commodity channel .

Mid-DE grades remain strategically important because encapsulation and spray drying connect food, supplement, and pharmaceutical-adjacent demand. Yet their broad applicability also makes them less naturally protected from competition than a tightly qualified oral-dose grade. Manufacturers should therefore treat DE as a route-to-market decision. The same starch platform can produce materially different economics depending on whether the grade is sold through bulk-food procurement, an encapsulation program, or a regulated excipient channel.

Maltodextrin Market Regional Analysis

North America

North America is the largest regional market, projected to increase from USD 1.481 billion in 2025 to USD 2.189 billion in 2035 at 4.0% CAGR. The United States is projected to rise from USD 1.318 billion to USD 1.948 billion. The region's advantage comes from deep corn-processing integration and large food, beverage, sports-nutrition, and pharmaceutical customer bases. U.S. HS 350510 exports totaled USD 500 million in 2023 , indicating an export platform alongside domestic consumption. Lower early-2024 U.S. corn cash prices, reported by USDA at roughly USD 4.74–5.21 per bushel, reduced input pressure but also increased the likelihood of price concessions in supply negotiations ^{[7]USDA Economic Research Service, Feed Outlook, March 2024, ers.usda.gov}.

Europe

Europe is projected to rise from USD 1.1 billion in 2025 to USD 1.412 billion in 2035 at 3.5% CAGR. It combines mature food demand with wheat- and potato-starch specialization, but energy and grain costs constrain its cost position. The European Union exported USD 926 million of HS 350510 products in 2023 ^{[8]World Bank WITS, European Union Dextrins and Modified Starches Exports by Destination Country, 2023, wits.worldbank.org}. Meanwhile, the 2024 production reductions reported in the European starch sector show that regional capacity economics can change quickly when industrial demand weakens. European suppliers are therefore better positioned where source-specific, specialty, or pharmaceutical requirements reward quality and documentation rather than lowest-cost bulk supply.

Asia Pacific

Asia Pacific is projected to grow from USD 1.12 billion in 2025 to USD 1.951 billion in 2035 at 5.7% CAGR, the fastest regional rate. China's role as both a large importer and a domestic processor demonstrates the region's complexity: it imported USD 540 million of HS 350510 products in 2024, principally from Thailand and Vietnam . India adds a different demand profile, with food processing and pharmaceutical manufacturing supported by domestic starch-derivative capability; Gulshan Polyols documents production from maize and non-GMO rice across multiple Indian facilities . Regulatory diversity across APAC makes local technical service and documentation important for suppliers seeking to scale across the region rather than merely ship volume into it.

Latin America

Latin America is projected to expand from USD 0.24 billion in 2025 to USD 0.368 billion in 2035 at 4.3% CAGR. Brazil's agricultural base and regional trade connections provide a feedstock and supply advantage, while Mexico benefits from proximity to North American starch supply and domestic food-and-beverage demand. Ingredion's annual-report disclosure identifies ALMEX, a Mexican ADM-Primient joint venture, within the competitive context for the region . The regional opportunity is linked to food-manufacturing expansion, but exchange-rate and import-cost exposure can make local or regionally integrated supply more valuable than a nominally lower-cost distant source.

Middle East & Africa

Middle East & Africa is projected to grow from USD 0.16 billion in 2025 to USD 0.19 billion in 2035 at 1.7% CAGR. The region remains relatively import dependent and price sensitive, making freight, distributor inventories, and currency conditions central to delivered cost. Growth in Gulf food manufacturing and broader processed-food consumption can add demand, but the lower forecast rate indicates that these catalysts do not yet offset the structural limits imposed by limited regional starch-processing capacity.

The most consequential supply-chain contest is not simply between regions; it is between supply models. Southeast Asian cassava exporters can compete on origin and clean-label positioning, whereas North American and European processors compete on integration, qualification history, and technical support. Buyers that require certified source identity may accept a different logistics profile than buyers optimizing for continuity and regional inventory. This distinction helps explain why trade volume alone cannot determine competitive strength.

Maltodextrin Market Share & Competitive Landscape

The top five companies account for approximately 42% of 2025 market revenue, while the top 15 account for 64%; the remaining 36% is distributed among smaller producers. Scale matters because it supports multi-origin sourcing, process control, and customer service, but pharmaceutical and specialty positions also depend on qualification and formulation depth.

AGRANA Group.

AGRANA Group is included in the competitive scope as a European starch-ingredient participant.

Archer Daniels Midland (ADM).

ADM's 2024 Form 10-K identifies Carbohydrate Solutions as part of its portfolio and reports corn at approximately 12% of revenue in both 2023 and 2024 ^{[9]Archer-Daniels-Midland Company, Form 10-K for Fiscal Year Ended December 31, 2024, sec.gov}. Its integrated grain-processing footprint supports participation across commodity and specialty carbohydrate channels.

Avebe.

Royal Avebe operates six production sites in the Netherlands, Germany, and Sweden . Its potato-starch platform provides a non-corn source option, while its drying-energy program is relevant to the economics of specialty powder production ^{[10]Avebe, Energy and Sustainability at Avebe, 2023, avebe.com}.

Cargill.

Cargill describes maltodextrin functions in personal-care products including film forming, binding, and humectancy . Its broad agricultural and logistics footprint supports continuity for customers with multi-regional sourcing requirements.

Golden Grain Group.

Golden Grain Group is included in the competitive scope as a Chinese starch-derivatives participant.

Grain Processing Corporation.

GPC's facilities include manufacturing locations in Iowa and Indiana , and its BRCGS certificate covers refining and packing maltodextrin and corn syrup solids at the Muscatine Maltrin Division . Its capacity investment in MALTRIN maltodextrin reflects an effort to support international demand .

Gulshan Polyols.

Gulshan Polyols reports maltodextrin production from maize and non-GMO rice through facilities in multiple Indian states . This source diversity is relevant to domestic and export customers that specify botanical origin.

Ingredion.

Ingredion's 2024 Form 10-K identifies competitive differentiation in functionality, price, and quality across its relevant business . Its tapioca-based TrueTrace product documentation provides a concrete non-GMO, chain-of-custody position .

Matsutani America.

Matsutani America is included in the competitive scope, with relevance in specialty carbohydrate and functional-food channels.

Mengzhou Tailijie.

Mengzhou Tailijie is included in the competitive scope as a Chinese maltodextrin participant.

Roquette Frères.

Roquette's GLUCIDEX IT 19 is positioned for pharmaceutical and nutraceutical oral-dosage uses . This exemplifies competition based on grade control and application support rather than commodity starch supply alone.

Tate & Lyle.

Tate & Lyle reports that its CLARIA G process reduces carbon footprint by 35% and water use by 34% relative to the previous technology . Sustainability-linked process differentiation can matter where customers include environmental criteria in ingredient selection.

Zhucheng Dongxiao Biotechnology.

Zhucheng Dongxiao Biotechnology is included in the competitive scope as a Chinese starch-hydrolysates participant.

Recent Industry Developments

In March 2024, Reuters reported that European starch makers reduced production as demand retreated from pandemic-era peaks and operating costs remained difficult . The event mattered for maltodextrin supply because it demonstrated how a broad starch-sector correction can affect throughput and pricing even when food and pharmaceutical uses are relatively more resilient.

Ingredion's published technical specification for GLOBE 10 DE non-GMO tapioca maltodextrin documents a TrueTrace chain-of-custody proposition . The development illustrates that clean-label differentiation is being embedded in the supply documentation of a starch-derived ingredient, allowing origin to become a purchasing criterion alongside DE and physical performance.

Grain Processing Corporation announced a multi-million-dollar expansion of MALTRIN maltodextrin capacity to support international growth . The investment is a capacity event rather than a forecast and reinforces the continuing importance of dedicated powder-processing infrastructure in supplying export-oriented customers.

Avebe has identified electric steam boilers and membrane concentration within its effort to reduce CO2 emissions by 30% by 2030 . This is a process-investment response to the energy intensity of potato-starch drying and provides a relevant benchmark for producers facing growing scrutiny of powder-processing emissions.